Diabetes Care:治疗糖尿病及其各种并发症究竟需要多少钱

2018-02-07 Heather_z727 来宝网

德国赫尔姆霍兹研究中心的科学家们对德国300000多名糖尿病患者的健康保险数据进行了研究。他们的报告发表在医学杂志《糖尿病护理》上,详细分析了治疗这种疾病并发症的费用。

2型糖尿病并发症的治疗费用】德国赫尔姆霍兹研究中心的科学家们对德国300000多名糖尿病患者的健康保险数据进行了研究。他们的报告发表在医学杂志《糖尿病护理》上,详细分析了治疗这种疾病并发症的费用。

据估计,德国大约有七百万人患有2型糖尿病。即使在早期,这种疾病也会对血管和其他器官造成损害。这包括可能导致失明的眼睛状况、可能导致肾功能衰竭的肾损害、可能导致截肢必要的足部问题以及严重的心血管疾病,包括心肌梗死或慢性心力衰竭。

研究人员表示:“我们想知道由法定医疗保险承担的相关费用的程度,也就是由整个社会承担的,因此我们研究了2012年至2015年期间316220名2型糖尿病患者的数据。与2型糖尿病并发症相关的高保健费用”

基于这些数据,研究人员对糖尿病相关并发症的成本进行了详细的评估。由于2型糖尿病在老年人中最常见,他们计算了60至69岁男性的费用。在发生有关并发症的季度,费用估计如下:

眼病(视网膜病变)大致700欧元;

盲症3000欧元;

肾脏损伤接近3400欧元;

(依赖透析)肾功能衰竭23000欧元;

糖尿病足1300欧元;

截肢接近14000欧元;

“此外,与心脑血管疾病相关的费用从心绞痛2700欧元到致命缺血性心脏病20000欧元不等,在最初出现这些并发症后的几个季度里,成本仍然很高。”

原始出处:

Katharina K?hm et al. Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany, Diabetes Care (2018). DOI: 10.2337/dc17-1763.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1760523, encodeId=5bb21e60523e3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Jan 04 18:08:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638403, encodeId=6c54163840303, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 18 19:08:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901965, encodeId=94bb19019651a, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 01 13:08:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757940, encodeId=3edd1e579407e, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Apr 10 00:08:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1760523, encodeId=5bb21e60523e3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Jan 04 18:08:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638403, encodeId=6c54163840303, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 18 19:08:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901965, encodeId=94bb19019651a, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 01 13:08:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757940, encodeId=3edd1e579407e, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Apr 10 00:08:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1760523, encodeId=5bb21e60523e3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Jan 04 18:08:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638403, encodeId=6c54163840303, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 18 19:08:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901965, encodeId=94bb19019651a, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 01 13:08:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757940, encodeId=3edd1e579407e, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Apr 10 00:08:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1760523, encodeId=5bb21e60523e3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Jan 04 18:08:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638403, encodeId=6c54163840303, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 18 19:08:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901965, encodeId=94bb19019651a, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 01 13:08:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757940, encodeId=3edd1e579407e, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Apr 10 00:08:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
    2018-04-10 丁鹏鹏

相关资讯

J Clin Periodontol:牙周炎和糖尿病相关的致病机制的研究

Taylor(Journal of Clinical Periodontology,2013,40,S113)关于牙周炎与糖尿病之间生物学关联的科学证据的更新。

阿根廷研究员为糖尿病患者开发新型 3D 生物打印伤口敷料

糖尿病患者往往特别容易受到皮肤伤口引起的细菌感染的影响。近日,阿根廷的一组研究员利用 3D 打印技术设计了一系列可定制的的伤口敷料,大大改善了伤口愈合的过程,防止了危险感染的传播。

糖尿病随着时间的发展是如何变化的,如何管理血糖才能趋向正常

糖尿病是一种慢性疾病,据统计,全球受到糖尿病伤害的人数正在不断攀升,预计到2050年,这一数字将会达到顶峰。

Dig Liver Dis:非肥胖的非酒精性脂肪性肝病患者患糖尿病的风险增加

研究结果表明,非肥胖的NAFLD患者患糖尿病的风险显著增加

Cell Metab: 科学家首次发现,胰岛素阻塞引起2型糖尿病,有望攻克这一疾病

在一项新的研究中,乌普萨拉大学和隆德大学的研究人员发现,在患有2型糖尿病的患者中,胰岛素分泌不能正常工作。该报告发表在《细胞代谢》杂志上。

Eye:研究确定糖尿病的又一大可怕的并发症,风险是普通人的六倍!

一项发表在《眼睛》杂志上的新研究表明,糖尿病患者患白内障的几率是普通人群的两倍,45岁至54岁人群的相对风险最高。